[1]
|
Wyse, D.G. and Gersh, B.J. (2004) Atrial fibrillation: A perspective: Thinking inside and outside the box. Circulation, 109, 3089-3095.
http://circ.ahajournals.org/content/109/25/3089.full.pdf+html
doi:10.1161/01.CIR.0000132611.01101.DC
|
[2]
|
Feinberg, W.M., Blackshear, J.L., Laupacis, A., Kronmal, R. and Hart, R.G. (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Archives of Internal Medicine, 155, 469-473.
http://www.ncbi.nlm.nih.gov/pubmed/7864703
doi:10.1001/archinte.1995.00430050045005
|
[3]
|
Go, A.S., Hylek, E.M., Phillips, K.A., Chang, Y., Henault, L.E., Selby, J.V. and Singer, D.E. (2001) Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Journal of the American Medical Association, 285, 2370-2375.
http://jama.ama-assn.org/content/285/18/2370.full.pdf+html
doi:10.1001/jama.285.18.2370
|
[4]
|
Chugh, S.S., Blackshear, J.L., Shen, W.K., Hammill, S.C. and Gersh, B.J. (2001) Epidemiology and natural history of atrial fibrillation: clinical implications. Journal of the American College of Cardiology, 37, 371-378.
http://content.onlinejacc.org/cgi/reprint/37/2/371.pdf
doi:10.1016/S0735-1097(00)01107-4
|
[5]
|
Wijffels, M.C., Kirchhof, C.J., Dorland, R. and Allessie, M.A. (1995) Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation, 92, 1954-1968.
http://circ.ahajournals.org/content/92/7/1954.full
|
[6]
|
Allessie, M., Ausma, J. and Schotten, U. (2002) Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovascular Research, 54, 230-246.
http://cardiovascres.oxfordjournals.org/content/54/2/230.full
doi:10.1016/S0008-6363(02)00258-4
|
[7]
|
de Vos, C.B., Pisters, R., Nieuwlaat, R., Prins, M.H., Tieleman, R.G., Coelen, R.J.S., van den Heijkant, A.C., Allessie, M.A. and Crijns, H.J.G.M. (2010) Progression from paroxysmal to persistent atrial fibrillation: clinical correlates and prognosis. Journal of the American College of Cardiology, 55, 725-731.
http://content.onlinejacc.org/cgi/content/full/55/8/725
doi:10.1016/j.jacc.2009.11.040
|
[8]
|
Jahangir, A., Lee, V., Friedman, P.A., Trusty, J.M., Hodge, D.O., Kopecky, S.L., Packer, D.L., Hammill, S.C., Shen, W.K. and Gersh, B.J. (2007) Long-term progression and outcomes with aging in patients with lone atrial fibrillation: A 30-year follow-up study. Circulation, 115, 3050-3056.
http://circ.ahajournals.org/content/115/24/3050.full doi:10.1161/CIRCULATIONAHA.106.644484
|
[9]
|
Komatsu, T., Nakamura, S., Saitou, E., Kobayashi, T., Kumagai, K. and Okumura, K. (2000) Long-term efficacy of antiarrhythmic drugs in the prevention of paroxysmal atrial fibrillation; significance of suffering period. Japanese Journal of Electrocardiology, 1, 27-32.
|
[10]
|
Kannel, W.B., Abbott, R.D., Savage, D.D. and McNamara, P.M. (1982) Epidemiologic features of chronic atrial fibrillation: The framingham study. New England Journal of Medicine, 306, 1018-1022.
http://www.ncbi.nlm.nih.gov/pubmed/7062992
doi:10.1056/NEJM198204293061703
|
[11]
|
Abe, Y., Fukunami, M., Yamada, T., Ohmori, M., Shimonagata, T., Kumagai, K., Kim, J., Sanada, S., Hori, M. and Hoki, N. (1997) Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography. Circulation, 96, 2612-2616.
http://circ.ahajournals.org/content/96/8/2612.long
|
[12]
|
Kerr, C.R., Humphries, K.H., Talajic, M., Klein, G.J., Connolly, S.J., Green, M., Boone, J., Sheldon, R., Dorian, P. and Newman, D. (2005) Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation. American Heart Journal, 149, 489-496.
http://www.medscape.com/viewarticle/502666
doi:10.1016/j.ahj.2004.09.053
|
[13]
|
Henningsen, K.M., Therkelsen, S.K., Johansen, J.S., Bruunsgaard, H. and Svendsen, J.H. (2009) Plasma YKL-40, a new biomarker for atrial fibrillation? Europace, 11, 1032-1036.
http://europace.oxfordjournals.org/content/11/8/1032.full doi:10.1093/europace/eup103
|
[14]
|
Chung, M.K., Martin, D.O., Sprecher, D., Wazni, O., Kanderian, A., Carnes, C.A., Bauer, J.A., Tchou, P.J., Niebauer, M.J., Natale, A. and van Wagoner, D.R. (2001) C-reactive protein elevation in patients with atrial arrhythmias : Inflammatory mechanisms and persistence of atrial fibrillation. Circulation, 104, 2886-2891.
http://circ.ahajournals.org/content/104/24/2886.full
doi:10.1161/hc4901.101760
|
[15]
|
Conway, D.S., Buggins, P., Hughes, E. and Lip, G.Y. (2004) Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. Journal of the American College of Cardiology, 43, 2075-2082.
http://content.onlinejacc.org/cgi/content/full/43/11/2075
doi:10.1016/j.jacc.2003.11.062
|
[16]
|
Van Wagoner, D.R. (2008) Oxidative stress and inflammation in atrial fibrillation: Role in pathogenesis and potential as a therapeutic target. Journal of Cardiovascular Pharmacology, 52, 306-313.
http://www.ncbi.nlm.nih.gov/pubmed/18791466
doi:10.1097/FJC.0b013e31817f9398
|
[17]
|
Liuba, I., Ahlmroth, H., Jonasson, L., Englund, A., Safstrom, K. and Walfridsson, H. (2008) Source of inflammatory markers in patients with atrial fibrillation. Europace, 10, 848-853.
http://europace.oxfordjournals.org/content/10/7/848.full doi:10.1093/europace/eun111
|
[18]
|
Ellinor, P.T., Low, A., Patton, K.K., Shea, M.A. and MacRae, C.A. (2006) C-reactive protein in lone atrial fibrillation. American Journal of Cardiology, 97, 1346-1350.
http://www.sciencedirect.com/science/article/pii/S0002914906001585
doi:10.1016/j.amjcard.2005.11.052
|
[19]
|
Roldan, V., Marin, F., Blann, A.D., Garcia, A., Marco, P., Sogorb, F. and Lip, G.Y. (2003) Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. European Heart Journal, 24, 1373-1380.
http://eurheartj.oxfordjournals.org/content/24/14/1373.full
doi:10.1016/S0195-668X(03)00239-2
|
[20]
|
Scridon, A., Morel, E., Nonin-Babary, E., Girerd, N., Fernandez, C., and Chevalier, P. (2012) Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation. Europace, in press.
http://europace.oxfordjournals.org/content/early/2012/02/02/europace.eur418.full
|
[21]
|
Li, J., Hampton, T., Morgan, J.P. and Simons, M. (1997) Stretch-induced VEGF expression in the heart. Journal of Clinical Investigations, 100, 18-24.
http://www.jci.org/articles/view/119510
|
[22]
|
Wong, A.K., Marais, H.J., Jutzy, K., Capestany, G.A. and Marais, G.E. (1991) Isolated atrial infarction in a patient with single vessel disease of the sinus node artery. Chest, 100, 255-256.
http://chestjournal.chestpubs.org/content/100/1/255.full.pdf+html
doi:10.1378/chest.100.1.255
|
[23]
|
Thijssen, V.L., van der Velden, H.M., van Ankeren, E.P., Ausma, J., Allessie, M.A., Borgers, M., van Eys, G.J. and Jongsma, H.J. (2002) Analysis of altered gene expression during sustained atrial fibrillation in the goat. Cardiovascular Research, 54, 427-437.
http://cardiovascres.oxfordjournals.org/content/54/2/427.full
doi:10.1016/S0008-6363(02)00260-2
|
[24]
|
Freeman, M.R., Scheck, F.X., Gagnon, M.L., Corless, C., Soker, S., Niknejad, K., Peoples, G.E. and Klagsbrun, M. (1995) Peripheral blood T-lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Research, 55, 4140-4145.
http://cancerres.aacrjournals.org/content/55/18/4140.full.pdf
|
[25]
|
Gaudry, M., Bregerie, O., Andrieu, V., El Benna, J., Pocidalo, M.A. and Hakim, J. (1997) Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood, 90, 4153-4161.
http://bloodjournal.hematologylibrary.org/content/90/10/4153.full.pdf
|
[26]
|
Mohle, R., Green, D., Moore, M.A.S., Nachman, R.L. and Rafii, S. (1997) Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proceedings of the National Academy of Sciences USA, 94, 663-668.
http://www.ncbi.nlm.nih.gov/pubmed/9012841
doi:10.1073/pnas.94.2.663
|
[27]
|
Seko, Y., Seko, Y., Takahashi, N., Shibuya, M. and Yazaki, Y. (1999) Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochemical and Biophysical Research Communications, 254, 462-465.
http://www.sciencedirect.com/science/article/pii/S0006291X98999697
doi:10.1006/bbrc.1998.9969
|
[28]
|
Kallergis, E.M., Manios, E.G., Kanoupakis, E.M., Mavrakis, H.E., Arfanakis, D.A., Maliaraki, N.E., Lathourakis, C.E., Chlouverakis, G.I. and Vardas, P.E. (2008) Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover. Journal of the American College of Cardiology, 52, 211-215.
http://content.onlinejacc.org/cgi/content/full/52/3/211
|
[29]
|
Gramley, F., Lorenzena, J., Koellensperger, E., Kettering, K., Weiss, C. and Munzel, T. (2010) Atrial fibrosis and atrial fibrillation: The role of the TGF-β1 signaling pathway. International Journal of Cardiology, 143, 405-413.
http://www.sciencedirect.com/science/article/pii/S0167527309003969
doi:10.1016/j.ijcard.2009.03.110
|
[30]
|
Chaudhary, N.I., Roth, G.J., Hilberg, F., Müller-Quernheim, J., Prasse, A., Zissel, G., Schnapp, A. and Park, J.E. (2007) Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. European Respiratory Journal, 29, 976-985.
http://erj.ersjournals.com/content/29/5/976.full
doi:10.1183/09031936.00152106
|
[31]
|
Hamada, N., Kuwano, K., Yamada, M., Hagimoto, N., Hiasa, K., Egashira, K., Nakashima, N., Maeyama, T., Yoshimi, M. and Nakanishi, Y. (2005) Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice. Journal of Immunology, 175, 1224-1231.
http://www.jimmunol.org/content/175/2/1224.full
|
[32]
|
Motomura, Y., Kanbayashi, H., Khan, W.I., Deng, Y., Blennerhassett, P.A., Margetts, P.J., Gauldie, J., Egashira, K. and Collins, S.M. (2005) The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-beta type II receptor gene transfer. American Journal of Physiology: Gastrointestinal and Liver Physiology, 288, G143-G150.
http://ajpgi.physiology.org/content/288/1/G143.full
|
[33]
|
Jahangir, A., Munger, T.M., Packer, D.L. and Crijns, H.J.G.M. (2001) Atrial fibrillation. In: Podrid, P.J. and Kowey, P.R. Eds., Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management, 2nd Edition, Lippincott Williams & Wilkins, Philadelphia, 457-499.
|
[34]
|
Tsang, T.S., Gersh, B.J., Appleton, C.P., Tajik, A.J., Barnes, M.E., Bailey, K.R., Oh, J.K., Leibson, C., Montgomery, S.C. and Seward, J.B. (2002) Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. Journal of the American College of Cardiology, 40, 1636-1644.
http://content.onlinejacc.org/cgi/content/full/40/9/1636
doi:10.1016/S0735-1097(02)02373-2
|
[35]
|
Wang, T.J., Parise, H., Levy, D., D’Agostino, R.B. Sr., Wolf, P.A., Vasan, R.S. and Benjamin, E.J. (2004) Obesity and the risk of new-onset atrial fibrillation. Journal of the American Medical Association, 292, 2471-2477.
http://jama.ama-assn.org/content/292/20/2471.full
doi:10.1001/jama.292.20.2471
|
[36]
|
Gami, A.S., Pressman, G., Caples, S.M., Kanagala, R., Gard, J.J., Davison, D.E., Malouf, J.F., Ammash, N.M., Friedman, P.A. and Somers, V.K. (2004) Association of atrial fibrillation and obstructive sleep apnea. Circulation, 110, 364-367.
http://circ.ahajournals.org/content/110/4/364.full
doi:10.1161/01.CIR.0000136587.68725.8E
|
[37]
|
Verdecchia, P., Reboldi, G., Gattobigio, R., Bentivoglio, M., Borgioni, C., Angeli, F., Carluccio, E., Sardone, M.G. and Porcellati, C. (2003) Atrial fibrillation in hypertension: Predictors and outcome. Hypertension, 41, 218-223.
http://hyper.ahajournals.org/content/41/2/218.full
|
[38]
|
Aviles, R.J., Martin, D.O., Apperson-Hansen, C., Houghtaling, P.L., Rautaharju, P., Kronmal, R.A., Tracy, R.P., Van Wagoner, D.R., Psaty, B.M., Lauer, M.S. and Chung, M.K. (2003) Inflammation as a risk factor for atrial fibrillation. Circulation, 108, 3006-3010.
http://circ.ahajournals.org/content/108/24/3006.full
doi:10.1161/01.CIR.0000103131.70301.4F
|
[39]
|
Nieuwlaat, R., Prins, M.H., Le Heuzey, J.Y., Vardas, P.E., Aliot, E., Santini, M., Cobbe, S.M., Widdershoven, J.W.M.G., Baur, L.H., Levy, S. and Crijns, H.J.G.M. (2008) Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: Follow-up of the Euro Heart Survey on Atrial Fibrillation. European Heart Journal, 29, 1181-1189.
http://eurheartj.oxfordjournals.org/content/29/9/1181.full
doi:10.1093/eurheartj/ehn139
|